甘肃医药
甘肅醫藥
감숙의약
Gansu Medical Journal
2015年
2期
94-95
,共2页
血肿穿刺置管引流术%高血压脑出血%小骨窗血肿清除术
血腫穿刺置管引流術%高血壓腦齣血%小骨窗血腫清除術
혈종천자치관인류술%고혈압뇌출혈%소골창혈종청제술
hematoma puncture and drainage%hypertensive cerebral hemorrhage%small bone window hematoma
目的：观察血肿穿刺置管引流术用于高血压脑出血的实际疗效，评价其临床应用价值。方法：选择152例高血压脑出血患者，随机分为观察组76例，采用血肿穿刺置管引流术进行治疗，以及对照组76例，采用小骨窗血肿清除术进行治疗，记录两组患者死亡率及术后1年日常生活能力（ADL）并进行比较。结果：观察组死亡率及术后1年ADL良好率分别为2.63%、81.58%，对照组分别为13.16%、67.11%，观察组及对照组死亡率及术后1年ADL良好率组间差异均具有统计学意义（P＜0.05）。结论：血肿穿刺置管引流术用于高血压脑出血的治疗，具有疗效显著，安全可靠的特点，值得临床推广应用。
目的：觀察血腫穿刺置管引流術用于高血壓腦齣血的實際療效，評價其臨床應用價值。方法：選擇152例高血壓腦齣血患者，隨機分為觀察組76例，採用血腫穿刺置管引流術進行治療，以及對照組76例，採用小骨窗血腫清除術進行治療，記錄兩組患者死亡率及術後1年日常生活能力（ADL）併進行比較。結果：觀察組死亡率及術後1年ADL良好率分彆為2.63%、81.58%，對照組分彆為13.16%、67.11%，觀察組及對照組死亡率及術後1年ADL良好率組間差異均具有統計學意義（P＜0.05）。結論：血腫穿刺置管引流術用于高血壓腦齣血的治療，具有療效顯著，安全可靠的特點，值得臨床推廣應用。
목적：관찰혈종천자치관인류술용우고혈압뇌출혈적실제료효，평개기림상응용개치。방법：선택152례고혈압뇌출혈환자，수궤분위관찰조76례，채용혈종천자치관인류술진행치료，이급대조조76례，채용소골창혈종청제술진행치료，기록량조환자사망솔급술후1년일상생활능력（ADL）병진행비교。결과：관찰조사망솔급술후1년ADL량호솔분별위2.63%、81.58%，대조조분별위13.16%、67.11%，관찰조급대조조사망솔급술후1년ADL량호솔조간차이균구유통계학의의（P＜0.05）。결론：혈종천자치관인류술용우고혈압뇌출혈적치료，구유료효현저，안전가고적특점，치득림상추엄응용。
Objective: To observe the hematoma puncture drainage for the actual efficacy of hypertensive intracerebral hemorrhage, and evaluate its clinical value. Methods: 152 cases of cerebral hemorrhage,76 cases were randomly divided into the treatment groups which were used the hematoma puncture drainage , and 76 cases in the control group which were used a small bone window hematoma. Mortality and after a year of daily living (ADL) in the two group were recorded and compared. Results: The 1-year mortality and postoperative ADL good rates were 2.63%,81.58% in the treatment group,were 13.16%,67.11% in the control group in which the differences were statistically significant (P<0.05). Conclusion: Hematoma puncture drainage for hypertensive cerebral hemorrhage have a significant effect,safe and reliable,which is worthy of clinical application.
